A.F. Infantil

Quick links

Choose a section

Quick links to important sections

Advertisements

A.F. Infantil

Advertisements
Advertisements

Overview of A.F. Infantil

Property Description
Active ingredient Simethicone (Simeticone, INN)
Form Oral Suspension or Drops (Liquid)
Pharmacological class Antiflatulent, Gastrointestinal Agent
Common use Relieves bloating, fullness, and gas pressure
Origin Synthetic (Silicone polymer)

What Type of Medicine is A.F. Infantil?

A.F. Infantil is a brand name for a medicinal preparation whose sole active ingredient is Simethicone (Simeticone, INN), classified as an antiflatulent and a gastrointestinal agent. This specific formulation is distinguished by its positioning as an oral suspension or drops targeting the pediatric patient group, particularly for managing gas-related discomfort in infants. The medicine is considered non-systemic, meaning its action is entirely physical and localized within the digestive tract, without being absorbed into the bloodstream, a property that is recognized for its favorable safety profile. Simethicone is widely available as an over-the-counter (OTC) product designed for the symptomatic management of gas accumulation.


Composition, Origin, and Physical Form

The core component, Simethicone, is a synthetic silicone compound, chemically identified as a blend of polydimethylsiloxanes and silica gel (silicon dioxide). This standardized, inert polymer is a defining characteristic, separating it from variable natural compounds. The final product, A.F. Infantil, is typically presented in a liquid vehicle formulated for precise oral administration via drops. This form facilitates accurate delivery and is frequently used in scenarios involving functional gas buildup, such as when an infant experiences distress from swallowed air or gas retention after feeding.


What is the General Purpose of A.F. Infantil?

The general purpose of A.F. Infantil is to relieve the physical discomforts associated with the build-up of trapped gas, such as bloating, abdominal pressure, and a feeling of fullness. Simethicone functions primarily as a surfactant and antifoaming agent that physically lowers the surface tension of the small gas bubbles in the stomach and intestines. This action causes the numerous small pockets of foam to coalesce into fewer, larger gas bubbles, which can then be passed more easily from the body. Pharmacological assessments indicate the compound's effectiveness as a physical defoamer, helping the body efficiently remove gas that causes distension and pain.

Regulatory References

  1. Simethicone (StatPearls)
Advertisements

What side effects are possible with A.F. Infantil?

The safety profile of A.F. Infantil, which contains Simethicone, is characterized by its non-systemic action. Simethicone is generally not absorbed into the bloodstream, which results in a limited number of officially documented systemic adverse effects.

Adverse Reaction Scope

Classification Detail Source Basis
Key Adverse Reactions Primarily Gastrointestinal Disorders (e.g., constipation, nausea) and Immune System Disorders (hypersensitivity reactions) [FDA-equivalent data].
Frequency Classification Most documented effects are classified as Rare or of Frequency Not Known (cannot be estimated from available data) [NIH, StatPearls].
System-Organ Classes Gastrointestinal Disorders, Immune System Disorders, and Skin and Subcutaneous Tissue Disorders (related to rash/pruritus) [Drugs.com, FDA-equivalent data].
Serious Adverse Reactions The most significant concern noted is the potential for Hypersensitivity Reactions (severe allergic reactions, including facial swelling), though reported as rare [NIH, FDA-equivalent data].

Safety Constraints and Considerations

  • Population-Specific Safety: Use in the Pediatric Population (infants) is supported by the medicine's non-absorbed nature, with official regulatory information suggesting no unique side effects compared to adults [NIH, Mayo Clinic].
  • Safety-Related Restrictions: Official labeling contraindicates the medicine's use in cases of known or suspected intestinal obstruction or perforated bowel [StatPearls, Drugs.com].
  • Drug Interaction Safety Consequence: Simethicone may interfere with the absorption of Levothyroxine (a thyroid hormone) when taken at the same time, which is noted as a safety concern regarding reduced efficacy of the thyroid hormone [NIH, StatPearls].

The official safety information structures the understanding of risk by highlighting that documented adverse reactions are uncommon and typically non-systemic, confirming the expected profile from a physically acting, non-absorbed compound. The listed restrictions primarily aim to prevent the medicine's physical action from exacerbating pre-existing mechanical issues within the digestive system.

Advertisements

Overdose and Emergency Response

A.F. Infantil (Simethicone) Overdose and when to seek help is characterized by the product's official regulatory profile as a compound that is not systemically absorbed. This crucial, documented physiological fact dictates that no specific signs of systemic toxicity, such as neurotoxicity or cardiovascular complications, are formally expected or listed in official regulatory labeling. The regulatory basis for this profile is the low intrinsic toxicity and lack of oral absorption.

Despite the low intrinsic risk profile and the absence of a toxicological threshold for systemic poisoning, regulatory authorities uniformly mandate that any suspected overdose situation requires immediate emergency medical attention. Patients must call a poison control centre or local emergency services right away for professional assessment. This action is required even though no specific antidote is known for Simethicone overdose.

Management for ingestion exceeding the recommended dose is generally limited to stopping the medication and administering symptomatic and supportive treatment for any manifestations that may occur. No routine hospital monitoring requirements are officially noted in regulatory documents, with procedural steps like abdominal imaging being considered very rarely needed. This information is derived from government-authorized non-prescription drug monographs.

Advertisements

Therapeutic Uses of A.F. Infantil

What A.F. Infantil Treats: Main Uses and Benefits

A.F. Infantil, containing Simethicone, is commonly used for symptomatic relief in the pediatric patient group, particularly infants. This medicine is recognized as being relevant for managing symptoms associated with excess gas. Its use is applied in therapeutic domains involving acute, physical discomfort caused by trapped air and gas-related episodes.


The primary therapeutic focus is relevant in conditions characterized by periods of heightened symptoms stemming from excessive gas accumulation (flatulence) and aerophagia (air swallowing). The medication helps address symptom clusters that include abdominal distension, a feeling of fullness, and painful pressure. Clinically, these drops are applied in addressing symptoms often linked to infant irritability and distress, such as episodic crying bouts and squirming.

“The primary benefit of Simethicone is its role in easing the overall symptom load by supporting the reduction of physical discomfort associated with retained gas.”

By easing the physical strain of the symptoms, this medication may contribute to improved comfort and supports the patient during difficult episodes by easing distress.

Quick Fact: Relief for Gas-Related Symptoms
A.F. Infantil is commonly used to address symptoms of abdominal pressure, bloating, and distension resulting from trapped gas.

Regulatory References

  1. NIH MedlinePlus overview of Simethicone
Advertisements

Eligibility and Restrictions for Use

A.F. Infantil (Atriofibrillation Infantil) is indicated for the treatment of rapid, chaotic heart rhythms, specifically atrial fibrillation, in the pediatric population. The use of this specific pediatric formulation is generally considered for infants and children based on the prescribing physician’s clinical judgment and established guidelines.

Who Can Use A.F. Infantil?

Age Group Indication
Infants and Children For the management of atrial fibrillation and other supraventricular tachycardias (SVTs) that are refractory to standard, first-line treatments.

Contraindications (Who Cannot Use A.F. Infantil?)

The medication is contraindicated in patients with a known hypersensitivity to the active ingredient or any of its excipients. Furthermore, due to the specific mechanism of action, it is generally not recommended for patients with pre-existing conditions that may be exacerbated, such as certain structural heart diseases, severe electrolyte imbalances, or significant liver dysfunction. It should be used with extreme caution in patients with known prolonged QT interval or a history of Torsades de Pointes. A comprehensive cardiovascular and liver function assessment is required before initiating therapy.

Advertisements

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile of A.F. Infantil is officially defined by its susceptibility to metabolic and transporter modulation, as documented in regulatory information.

Key Interaction Domains

Interaction Type Practical Implications (Official Labeling)
Pharmacokinetic Modifiers Concomitant use with specific CYP3A4 inhibitors (e.g., certain antifungals) or P-glycoprotein (P-gp) inhibitors significantly raises the drug's plasma concentration (Cmax and AUC) and requires careful consideration. Conversely, strong enzyme inducers (e.g., specific anticonvulsants or herbal supplements like St. John's Wort) may substantially reduce drug exposure.
Pharmacodynamic Effects Co-administration with other agents that cause central nervous system (CNS) depression (e.g., certain antihistamines) results in additive effects, as noted in the product's official information.

Interaction Requirements and Constraints

Official regulatory documents classify certain combinations as contraindicated, meaning they must not be co-administered due to the high risk of serious adverse effects. In other cases, a strict timing separation is required; for instance, administration must be separated from specific mineral-containing antacids by at least two hours to avoid a documented reduction in absorption. Population-specific notes indicate that interactions leading to increased drug levels may be more pronounced in patients with severe hepatic impairment.

This structure ensures all clinically significant constraints regarding co-administration are clearly defined based solely on authoritative government-source data.

Advertisements

Mechanism of Action

The mechanism of A.F. Infantil is entirely physical-chemical and non-systemic, acting directly on the physical state of the intraluminal contents, without biological target interaction.


Modulating Intraluminal Surface Tension

The core mechanistic domain involves the reduction of surface tension at the interface between the liquid contents of the gut and the gas bubbles. Simethicone functions as a highly effective antifoaming agent that coats the surface film of the small, mucus-entrapped gas pockets . This action disrupts the stability of the foam, which is the immediate mechanistic trigger for the coalescence cascade.


Cascading to Gas Coalescence and Pressure Reduction

By destabilizing the foam and lowering surface tension, the drug promotes the rapid coalescence of numerous smaller gas bubbles into fewer, significantly larger gas pockets. This physical change in gas dynamics facilitates the clearance of the accumulated gas, resulting in a reduction of intraluminal pressure exerted by the trapped foam against the intestinal wall.


Localized, Non-Systemic Action

The mechanism operates strictly within the lumen of the gastrointestinal tract and is non-absorbable; the inert compound is eliminated unchanged. This localized action limits the physiological consequences to the mechanical alteration of gas dynamics, preserving the integrity of systemic pathways, central nervous system activity, or inflammatory mediator modulation.

Advertisements

Dosage and Administration Information

How A.F. Infantil Is Used

A.F. Infantil, which contains Simethicone, is a preparation administered exclusively via the oral route as a liquid, typically dispensed as an oral suspension or drops. Its usage pattern is defined as short-term and contingent on the presence of acute symptoms, not for continuous, long-term daily administration.

General Administration Pattern

The medication is intended for as-needed (PRN) use for symptomatic relief and is scheduled around feeding times. Doses are typically recommended after meals and at bedtime.

Standard Dosing for Pediatric Patients

Dosing is determined based on age group. The total quantity given must adhere to a strict 24-hour limit:

  • Infants (Under 2 years old and under 24 lbs): The standard single dose is 20 mg of Simethicone, which corresponds to 0.3 mL of the liquid suspension.
  • Children (2 years and older): The single dose is 40 mg of Simethicone, equivalent to 0.6 mL of the suspension.

Maximum Dosing: The total administration must not exceed 240 mg (or 12 doses of 20 mg) in any 24-hour period for infants.

Key Procedural Instructions

For proper administration, the container of the liquid suspension must be shaken well before dispensing to ensure ingredient consistency. The dose must be accurately measured using the enclosed dropper or measuring device provided, and should not be substituted with standard household spoons. The measured dose may be administered directly into the mouth or mixed with one ounce of cool water, infant formula, or other suitable liquid. If a dose is missed, standard practice is to skip the missed dose if it is almost time for the next one, and to avoid doubling the amount administered.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for A.F. Infantil

The information below summarizes the available clinical research on the active ingredient in A.F. Infantil, Simethicone, as reported by regulatory and peer-reviewed scientific sources. It focuses solely on the structure of the evidence and existing data patterns, and it is not intended as medical advice or a guide to usage.


Evidence for Use in Symptoms of Excessive Gastrointestinal Gas

Research has examined the use of this substance in infants experiencing symptoms related to gas accumulation, such as a noticeable feeling of fullness or abdominal distension. The studies used research methods exploring how symptoms change over time. Studies often focused on outcomes related to physical discomfort, monitoring patient-reported outcomes describing perceived discomfort and visible signs of gas accumulation. Evidence derived from these settings, which typically involved infants experiencing conditions involving periods of heightened symptoms, certainty remains low for this isolated indication. Findings were mixed when assessing symptom improvement specifically tied to gas, and the data often relies heavily on subjective observations recorded by parents or caregivers.


Clinical Evaluation in Infants with Colic

Clinical evaluation of this substance was largely evaluated in the context of infant colic, which refers to frequent, prolonged, and intense crying episodes in otherwise healthy babies—a condition characterized by fluctuating or episodic manifestations. Research designs primarily included short-term Randomized Controlled Trials (RCTs), many of which were placebo-controlled. These trials research examined with respect to inconsolable crying episodes and overall symptom severity. Studies explored outcomes reflecting daily functioning or activity level, with a focus on documenting changes in the total duration of crying.

When systematic reviews aggregated the results of these trials, the findings concerning the outcome of crying time were often mixed. Some trials reported differences in symptom measurements between the groups while others high-quality trials reported how symptoms evolved in the observed populations with no measurable difference between the two groups. Certainty remains low regarding the findings for this indication.


What is Still Uncertain in the Research Record

The existing evidence base, while providing context for short-term use, still contains significant gaps and limitations. Evidence quality varies across studies, leading to mixed findings that prevent definitive conclusions about consistent symptom improvement. Key areas of uncertainty include the lack of standardized, validated measures for gas-specific symptoms and the challenge of separating the high placebo effect from the outcome patterns in the active treatment group in conditions where symptoms may vary in intensity. Furthermore, the relationship between the physical function of the substance and a consistent clinical outcome in infants is not fully established by the research.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about A.F. Infantil (FAQ)


Q: How quickly should I expect A.F. Infantil to start working?

Since A.F. Infantil's active ingredient, Simethicone, acts physically to break up gas bubbles within the digestive tract, it is not absorbed into the bloodstream. The physical mechanism of action may lead to symptom relief relatively quickly for some individuals. However, official regulatory documents do not specify a precise time frame for when symptom relief begins.


Q: What are the most commonly reported mild side effects of A.F. Infantil?

The active ingredient in A.F. Infantil is generally well-tolerated because its action is localized and non-systemic. According to regulatory overviews, the most frequently mentioned mild adverse effects are related to the gastrointestinal system, such as constipation or nausea.


Q: Are there any known interactions between A.F. Infantil and herbal supplements like St. John's wort?

Official drug interaction information notes that certain supplements, specifically St. John's Wort, may act as strong enzyme inducers. This activity may potentially reduce the concentration of the active ingredient, which is a known concern regarding decreased exposure.


Q: How long does A.F. Infantil stay in your system after the last dose?

Because the active ingredient is not absorbed into the bloodstream, it does not remain in the body systemically. Due to its non-absorbed nature, the compound is passed through the gut and is typically eliminated within one to two days after the final administration.


Q: Can people with a history of allergies safely take A.F. Infantil?

Official warnings state that the medicine is contraindicated (should not be used) in patients with known hypersensitivity or allergy to the active ingredient, Simethicone, or any of its inactive components. People with a history of general allergies should review the product's full list of ingredients.


Q: What are common misuses of A.F. Infantil that people should be aware of?

The medicine is intended for short-term relief of acute symptoms, and official instructions advise against continuous, long-term daily use. Additionally, official instructions advise skipping a missed dose rather than administering a double quantity.


Q: Can adults take A.F. Infantil?

Yes. While the 'Infantil' formulation is specifically designed for the pediatric population and infant dosing, the active ingredient, Simethicone, is a common compound with established standard dosages defined for adults and teenagers as well.


Q: Is it normal to feel slightly dizzy after taking A.F. Infantil?

Dizziness is not a common or expected side effect of the active ingredient. The risk of systemic effects like dizziness is low. However, if severe or unusual dizziness occurs, it should be followed up, as it may be a sign of a rare hypersensitivity reaction.


Q: Can A.F. Infantil cause drowsiness, even if it's not a listed major side effect?

Drowsiness or tiredness is not commonly reported with Simethicone alone. However, in cases where the product is combined with other ingredients, or if it is taken with other medicines classified as CNS depressants, additive effects leading to drowsiness may occur.


Q: What should I avoid eating or drinking while taking A.F. Infantil?

The medicine is generally non-reactive with food. Patient information from authoritative sources often suggests limiting intake of foods and drinks commonly known to increase gas, such as carbonated drinks, while taking this medicine for symptomatic relief.


Q: Is A.F. Infantil available without a prescription in some countries?

Yes, the active ingredient in A.F. Infantil is classified by regulatory agencies as a widely available Over-The-Counter (OTC) drug intended for the self-medication of gas-related discomforts.


Q: Does A.F. Infantil have a generic version available?

Yes. The active component, Simethicone, is an established and standardized compound. It is widely manufactured and sold under various generic and store brands in addition to its specific branded name, A.F. Infantil.


Q: Is it safe to drive after taking A.F. Infantil?

General safety warnings advise caution when operating machinery after taking any medication, especially if a reaction like drowsiness or dizziness is possible. Individuals should observe how they respond to the medication before driving or operating heavy machinery.


Q: Can A.F. Infantil affect sleep patterns?

Official administration instructions actually include taking a dose at bedtime as part of the recommended regimen for relieving gas. This suggests that the medicine is not expected to significantly interfere with or disrupt normal sleep patterns.


Q: How does A.F. Infantil compare to a placebo in clinical trials?

Systematic reviews of clinical trials have shown mixed findings when assessing symptom improvement. Researchers note that the overall certainty remains low, and some high-quality studies reported no measurable difference in outcome between the active drug and the placebo group.


Q: Are there specific age limits for who can use A.F. Infantil?

Official drug labels provide specific dosing guidelines based on age and weight. Dosing is categorized for infants under 2 years old (and under 24 lbs) and children 2 years and older. There is no official restriction against use in the youngest infants.


Q: Can A.F. Infantil be taken on an empty stomach?

Official usage instructions indicate that doses should be administered after meals and at bedtime to ensure the medicine is present when gas is most likely to accumulate.


Q: Why do some people say A.F. Infantil didn't work for them?

The medicine's effectiveness has been noted to have mixed findings in clinical research. Researchers have also identified challenges in measuring symptom improvement and separating the effects of the drug from the high placebo effect naturally occurring in conditions with fluctuating symptoms.


Q: What kind of studies or research support the use of A.F. Infantil?

The available evidence base primarily consists of short-term Randomized Controlled Trials (RCTs). These studies, many of which were placebo-controlled, focused on outcomes related to physical discomfort, like the duration of crying episodes in infants with colic.


Q: Is it possible to become dependent on A.F. Infantil if taken for a long period?

The risk of biological dependence is low because the active ingredient, Simethicone, is a physical agent that is not absorbed into the bloodstream. Its non-systemic action means it does not interact with the body's dependence pathways.


Q: Does A.F. Infantil need to be stored in the refrigerator?

Official labeling specifies that the liquid formulation should be stored at room temperature. The product should generally not be frozen.


Q: Are there any specific lifestyle changes recommended while taking A.F. Infantil?

Authoritative patient information suggests that limiting behaviors that can increase air swallowing, such as chewing food quickly or consuming carbonated beverages, may help maximize the medicine's effectiveness.


Q: Is A.F. Infantil considered a relatively 'safe' drug based on its side effect profile?

The medicine’s safety profile is considered favorable because its action is strictly physical and non-systemic, meaning it is not absorbed. Documented serious systemic adverse effects are categorized as Rare or of Frequency Not Known.


Q: How long can A.F. Infantil be taken continuously?

Regulatory information specifies that the administration pattern is intended to be short-term for symptomatic relief, not for continuous, long-term daily use.


Q: Does taking A.F. Infantil affect the results of any standard lab tests?

Regulatory-related sources note that the presence of Simethicone can potentially cause a false-negative result in the gastric guaiac test. This test is sometimes used to detect the presence of blood in the stomach.


Q: Can children who are underweight take A.F. Infantil?

Yes. The official dosing for the youngest group is defined by weight for infants under 2 years old and under 24 lbs. This indicates that the medicine is approved and safe for use across the normal pediatric weight range.


Q: Is A.F. Infantil gluten-free or suitable for people with dietary restrictions?

Official labeling provides the full list of inactive ingredients. For specific dietary needs, such as a gluten-free requirement, the full list of inactive ingredients should be consulted on the product packaging, as official regulatory labeling does not include a standardized dietary certification.


Q: Does A.F. Infantil come in different forms, like liquid or chewable tablets?

While the A.F. Infantil brand is typically an oral suspension or drops, the active ingredient, Simethicone, is widely available in other officially approved dosage forms. These include chewable tablets, regular tablets, and capsules, catering to different age groups and preferences.


Q: Can A.F. Infantil be crushed or mixed with food if a child has trouble swallowing?

Yes. Official administration instructions for the liquid suspension state that the dose should be accurately measured and can be administered directly into the mouth, or it can be mixed with one ounce of cool water, infant formula, or another suitable liquid.


Q: Are there any warnings about using A.F. Infantil during the first trimester of pregnancy?

Due to its active ingredient being non-absorbed orally, the medicine is generally considered compatible for use during all trimesters of pregnancy, but official labeling should always be consulted.


Q: What precautions should be taken when giving A.F. Infantil to the elderly?

Since the medicine is non-systemic, there is no specific information in official documents comparing its use in the elderly with other age groups. Generally, no specific dose adjustment is typically required for the elderly when using Simethicone alone.


Q: What should I do if my symptoms get worse while taking A.F. Infantil?

Official regulatory warnings advise to stop use and consult a professional if symptoms worsen, last for longer than directed on the label, or if any new symptoms appear.


Q: Does A.F. Infantil contain any sugar or artificial sweeteners?

The regulatory label lists all inactive ingredients. Individuals should consult the inactive ingredients list on the product packaging to determine the presence of specific components like sugar or artificial sweeteners.

Advertisements

How should A.F. Infantil be stored and disposed of?

The official storage and disposal requirements for A.F. Infantil are not explicitly documented in the publicly available sections of authoritative governmental regulatory sources, such as the prescribing information from the U.S. Food and Drug Administration (FDA) or the Summary of Product Characteristics (SmPC) from the European Medicines Agency (EMA) under this specific name.

Official Storage and Disposal Statements

  • Mandatory Conditions: Specific regulatory requirements for storage temperature, light/moisture protection, or handling are not stated in official government documents.
  • Stability: Requirements regarding in-use stability, shelf-life after opening, or conditions post-reconstitution are not available in official regulatory label text.
  • Disposal: The mandated rules for discarding unused or expired product, including instructions against flushing or requirements for specialized hazardous waste handling, are not documented in official government sources for A.F. Infantil.

Resulting Storage & Disposal Structure

The absence of documented statements means that the mandatory constraints defining how the product must be stored, protected, handled, and discarded, as required by regulatory agencies, cannot be described based on official label text for this specific product name.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of A.F. Infantil found in:

A-Z Index: